Citigroup’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Citigroup’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-77,622	Closed	-$3.27M	–	5840
2023 Q2	$3.27M	Sell	77,622 -378,318	-83%	-$15.3M	﹤0.01%	1791
2023 Q1	$16.2M	Buy	455,940 +423,221	+1,294%	+$15.4M	0.01%	918
2022 Q4	$1.2M	Buy	32,719 +1,580	+5%	+$62.5K	﹤0.01%	2449
2022 Q3	$1.47M	Buy	31,139 +13,464	+76%	+$870K	﹤0.01%	2401
2022 Q2	$1.27M	Sell	17,675 -1,090	-6%	-$79.7K	﹤0.01%	2440
2022 Q1	$1.52M	Sell	18,765 -474	-2%	-$40.1K	﹤0.01%	2575
2021 Q4	$1.98M	Sell	19,239 -7,413	-28%	-$712K	﹤0.01%	2633
2021 Q3	$2.33M	Sell	26,652 -20,266	-43%	-$1.83M	﹤0.01%	2416
2021 Q2	$4.2M	Buy	46,918 +20,114	+75%	+$1.7M	﹤0.01%	2050
2021 Q1	$2.03M	Sell	26,804 -8,873	-25%	-$669K	﹤0.01%	2474
2020 Q4	$2.43M	Buy	35,677 +15,202	+74%	+$948K	﹤0.01%	2674
2020 Q3	$1.09M	Sell	20,475 -12,132	-37%	-$722K	﹤0.01%	3195
2020 Q2	$1.9M	Sell	32,607 -1,414	-4%	-$76K	﹤0.01%	2864
2020 Q1	$1.34M	Buy	34,021 +2,484	+8%	+$145K	﹤0.01%	2870
2019 Q4	$1.88M	Sell	31,537 -17,314	-35%	-$931K	﹤0.01%	3055
2019 Q3	$2.6M	Buy	48,851 +29,891	+158%	+$1.53M	﹤0.01%	2578
2019 Q2	$969K	Buy	18,960 +11,340	+149%	+$528K	﹤0.01%	3669
2019 Q1	$395K	Sell	7,620 -58,444	-88%	-$2.83M	﹤0.01%	4437
2018 Q4	$2.6M	Buy	66,064 +7,902	+14%	+$367K	﹤0.01%	2428
2018 Q3	$3M	Buy	58,162 +56,528	+3,459%	+$2.77M	﹤0.01%	2343
2018 Q2	$77K	Sell	1,634 -246	-13%	-$10.2K	﹤0.01%	5945
2018 Q1	$66K	Sell	1,880 -318	-14%	-$12.5K	﹤0.01%	5965
2017 Q4	$96K	Sell	2,198 -42,069	-95%	-$1.97M	﹤0.01%	5678
2017 Q3	$2.31M	Buy	44,267 +39,476	+824%	+$2.2M	﹤0.01%	2505
2017 Q2	$281K	Buy	4,791 +4,060	+555%	+$211K	﹤0.01%	4503
2017 Q1	$33K	Buy	731 +402	+122%	+$20K	﹤0.01%	5976
2016 Q4	$17K	Hold	329	–	–	﹤0.01%	6597
2016 Q3	$15K	Buy	329 +50	+18%	+$2.17K	﹤0.01%	6361
2016 Q2	$11K	Sell	279 -17,770	-98%	-$781K	﹤0.01%	6513
2016 Q1	$744K	Sell	18,049 -1,624	-8%	-$66.9K	﹤0.01%	3687
2015 Q4	$954K	Sell	19,673 -4,124	-17%	-$183K	﹤0.01%	3191
2015 Q3	$952K	Sell	23,797 -19,885	-46%	-$869K	﹤0.01%	3135
2015 Q2	$1.75M	Buy	43,682 +24,460	+127%	+$844K	﹤0.01%	2650
2015 Q1	$630K	Buy	19,222 +17,624	+1,103%	+$487K	﹤0.01%	3524
2014 Q4	$41K	Buy	+1,598	New	+$38K	﹤0.01%	5822

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Citigroup's SYNH Position: Q3 2023 in Review

Citigroup sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 77,622 shares — an estimated $3.27M sold.

Citigroup first reported a position in SYNH in Q4 2014 and held it in 35 quarters. The position peaked at $16.2M in Q1 2023. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

Citigroup reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Citigroup sold 77,622 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $3.27M.
Citigroup first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2014 and held it in 35 quarters.
Citigroup's Syneos Health, Inc. Class A Common Stock position peaked at $16.2M in Q1 2023.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Citigroup's 13F filing for Q3 2023, filed 9 Nov 2023.